# A Study to Evaluate the Safety of mRNA-0184 in Participants With Heart Failure

> **NCT05659264** · PHASE1 · COMPLETED · sponsor: **ModernaTX, Inc.** · enrollment: 48 (actual)

## Conditions studied

- Chronic Heart Failure

## Interventions

- **DRUG:** mRNA-0184
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05659264
- **Lead sponsor:** ModernaTX, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-05
- **Primary completion:** 2024-12-17
- **Final completion:** 2024-12-17
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2025-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05659264

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05659264, "A Study to Evaluate the Safety of mRNA-0184 in Participants With Heart Failure". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05659264. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*